Federal Judge Tosses The First AndroGel Bellwether Verdict
Federal Judge Tosses The First AndroGel Bellwether Verdict
Introduction
The first AndroGel bellwether trial announced in favor of the plaintiff awarding him $150 million as punitive damages and no compensatory damages in June 2017 was tossed by the U.S. District Judge Matthew F. Kennelly, overseeing 6,000 plus testosterone replacement lawsuits centralized under MDL 2545 (In re: Testosterone Replacement Therapy Products Liability Litigation). The $150 million verdict was announced to punish AbbVie for its conduct in spite of acknowledging that the plaintiff’s heart attack was not caused by AbbVie’s product in question. This decision was based on the fact that the federal judge found the jury conclusions “logically incompatible.’’ He further ordered a new trial for this case to be convened on March 5, with a pretrial status conference scheduled for February 28th.
Latest News
title demo for news
Zantac Settles 4,000 Lawsuits in U.S. Courts
Sanofi has announced a settlement agreement regarding approximately 4,000 Zantac cancer lawsuits filed in state courts across the country.
…Valsartan Recall Lawsuit Set for Trial
Years after the initiation of Valsartan recalls, the U.S. District Judge overseeing lawsuits filed by individuals harmed by tainted versions of…